Neutral impactOrders & Deals
Stocks to watch, Oct 26: Raymond, RailTel, KEC Intl, Honasa, BL Kashyap, Lupin, Orchid Pharma, Gland Pharma among 15 stocks to remain in focus
BusinessLine 1 hr ago·26 Oct 2026, 1:17 am
Orchid Pharma has announced a strategic licensing agreement with a Latin American partner, granting them the rights to develop and commercialize specific formulations in the region. This move is significant as it expands the company's global footprint and diversifies its revenue streams beyond domestic markets. For investors, this partnership signals an effort to leverage international demand and reduce reliance on a single market.
The deal could enhance Orchid Pharma's valuation by opening new growth avenues, though the actual financial impact will depend on the performance of the licensed products. Investors should monitor the progress of these launches and any updates on regulatory approvals in the target region. Keeping an eye on the company's future earnings reports will be key to gauging the success of this expansion strategy.
Excerpt from BusinessLine
The Board of Directors Raymond Ltd has approved a proposal to change the name of the company to Raymond Aerospace, Defence & Engineering Ltd. RailTel Corporation of India Ltd has received the Letter of Intent (LoI) from Munitions India Ltd for Rs 20.04 crore. The order is for setting up DC & DR Center on IaaS platform…Read the original at BusinessLine
Affected stocks
Neutral4 stocks
Orchid Pharma
ORCHPHARMA Neutral
₹823.30
GLAND
GLAND Neutral
—
KEC
KEC Neutral
—
LUPIN
LUPIN Neutral
—
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Orchid Pharma (ORCHPHARMA).
- Category: Orders & Deals.
- Also mentions GLAND, KEC, LUPIN.
Why it matters
A routine update for Orchid Pharma. Use the price and stock snapshot to gauge how the market is responding.
